PFF urges patients to use only FDA-approved oxygen delivery devices

Screen Shot 2023 05 09 At 3 14 01 Pm

The medical advisory board of the Pulmonary Fibrosis Foundation (PFF) has issued a position statement on non-prescription supplemental oxygen. Patients living with pulmonary fibrosis should have a prescription for oxygen from their health care provider and should only use FDA-approved oxygen delivery devices.

The statement advises the patient community to use only FDA-approved oxygen delivery devices as prescribed by their doctor. Individuals should not purchase an oxygen supply device without a prescription from a health care provider because doing so may lead to serious health problems. In addition, non-FDA approved oxygen delivery systems may not reliably deliver oxygen.Amy Hajari Case, MDAmy Hajari Case, MD

"Supplemental oxygen therapy is necessary and beneficial to many people living with PF. Oxygen users often prefer portable oxygen concentrators (POC) so they can remain active and mobile. Unfortunately, existing POCs have limitations, such as short battery life and inadequate oxygen flow," said Amy Hajari Case, MD, PFF's senior medical advisor for education and awareness. "However, non-FDA approved portable oxygen concentrators available online are not the solution. Patients should always speak with their health care provider before any out-of-pocket purchase of a portable oxygen concentrator."


More in Pulmonary
Page 1 of 16
Next Page